TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 2 | 1 | -4 | -17 | -21 | -29 | -32 | -17 |
| P | %wins | 50 | 50 | 0 | 0 | 0 | 0 | 17 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/17/14 08:00 | 9/16/14 | OPXA | Opexa Therapeutics, Inc. | TX | Health | Drug | Pharmaceutical Preparations | Warma Neil K | TX | DO | P,CEO | P | 11 | 1.11 | 0 | 10 | 10 | 108 | D | -63 | -35 | -49 | -34 | -27 | -24 | -23 | -19 | -3 | -11 | -28 | -33 | -41 | -57 |
6/15/10 17:34 | 6/11/10 | OPXA | Opexa Therapeutics, Inc. | TX | Health | Drug | Pharmaceutical Preparations | Warma Neil K | TX | DO | P,CEO | P.m | 13 | 1.63 | 0 | 8 | 33 | 32 | D | 62 | 184 | -15 | -19 | -33 | -7 | -4 | 1 | 5 | 3 | -6 | -8 | -17 | -6 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |